
New England Biolabs, Inc. is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (China), China, covering academic research published from 2003 to 2025. Read More.
Open Access Percentage
73%
Total
Publications
256
Total Open
Publications
188
Total
Citations
5.9K
Open Access
Percentage
73%
Total
Publications
256
Total Open
Publications
188
Total
Citations
5.9K
Breakdown
Publisher Open
14%
Both
34%
Other Platform Open
23%
Closed
29%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 59%
66
Hybrid 27%
30
No Guarantees 14%
16
Other Platform Open
Domain 63%
84
Institution 34%
45
Preprint 32%
43
Other Internet 6%
8
Public 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 84 |
doaj.org OAI-PMH Repository | Institution | 38 |
bioRxiv | Preprint | 23 |
Research Square | Preprint | 20 |
DOI | Other Internet | 8 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 5 |
Europe PMC | Domain | 3 |
Boston University | Institution | 2 |
Utrecht University | Institution | 1 |
Unknown Repository | Other Internet | 1 |